| http://www.w3.org/ns/prov#value | - severity of the arrhythmia or other cardiac/cardiovascular event being prevented or reduced.The compound to be administered can be formulated by admixing with any of a number of suitable pharmaceutical diluents and carriers such as lactose, sucrose, starch powder, cellulose, calcium sulfate, sodium benzoate and the like.
|
